95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.82%
Revenue growth at 50-75% of FNV's 13.98%. Martin Whitman would worry about competitiveness or product relevance.
27.82%
Gross profit growth similar to FNV's 29.27%. Walter Schloss would assume both firms track common industry trends.
33.04%
EBIT growth 1.25-1.5x FNV's 25.00%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
33.04%
Operating income growth at 75-90% of FNV's 37.76%. Bill Ackman would demand a plan to enhance operating leverage.
37.61%
Net income growth 1.25-1.5x FNV's 28.61%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
35.71%
EPS growth 1.25-1.5x FNV's 29.17%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
35.71%
Diluted EPS growth 1.25-1.5x FNV's 25.00%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
0.90%
Share count expansion well above FNV's 0.17%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.13%
Diluted share count expanding well above FNV's 0.50%. Michael Burry would fear significant dilution to existing owners' stakes.
-47.91%
Dividend reduction while FNV stands at 2.22%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
20.34%
OCF growth under 50% of FNV's 103.77%. Michael Burry might suspect questionable revenue recognition or rising costs.
-582.88%
Negative FCF growth while FNV is at 198.81%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
179.16%
10Y revenue/share CAGR 1.25-1.5x FNV's 142.02%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
0.97%
5Y revenue/share CAGR under 50% of FNV's 8.37%. Michael Burry would suspect a significant competitive gap or product weakness.
13.13%
3Y revenue/share CAGR under 50% of FNV's 43.59%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
185.85%
10Y OCF/share CAGR 1.25-1.5x FNV's 161.67%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
-22.53%
Negative 5Y OCF/share CAGR while FNV is at 35.96%. Joel Greenblatt would question the firm’s operational model or cost structure.
9.91%
3Y OCF/share CAGR under 50% of FNV's 118.17%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
84.25%
Below 50% of FNV's 209.68%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-50.72%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-13.06%
Negative 3Y CAGR while FNV is 27.11%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
302.23%
10Y equity/share CAGR above 1.5x FNV's 55.84%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
57.24%
5Y equity/share CAGR above 1.5x FNV's 20.10%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
20.67%
3Y equity/share CAGR above 1.5x FNV's 11.03%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
46.03%
5Y dividend/share CAGR 1.25-1.5x FNV's 41.42%. Bruce Berkowitz verifies that high dividend hikes remain sustainable, not a sign of over-distribution.
-56.25%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-15.57%
Firm’s AR is declining while FNV shows 28.37%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
13.75%
Asset growth above 1.5x FNV's 0.98%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
1.65%
BV/share growth above 1.5x FNV's 0.56%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
90.51%
Debt growth of 90.51% while FNV is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
-8.58%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.